Antitussiva

Antitussiva, or cough suppressants, are medicines that reduce coughing by dampening the cough reflex. They are typically used for dry, nonproductive coughs and are not generally recommended for productive coughs, where coughing helps clear mucus. They may be used alone or in combination preparations with other cold medicines.

Most antitussiva act on the cough reflex through central or peripheral mechanisms. Central acting agents affect the brain’s cough center, while peripheral agents reduce stimulation in the airways. Examples of central agents include dextromethorphan and, in some regions, codeine. Peripheral agents include benzonatate, which anesthetizes cough receptors in the lungs and airways. Other drugs such as noscapine and pholcodine are used in certain countries.

Common active ingredients and considerations: dextromethorphan is widely available over the counter in many places; codeine-containing formulations are effective but carry risks of sedation, dependence, and respiratory depression and are often prescription-only. Benzonatate is a non-opioid option that acts peripherally. Side effects can include drowsiness, dizziness, and nausea; opioids carry additional risks, especially in children, the elderly, or those with lung disease. Antitussiva are not recommended for persistent cough without medical evaluation and should be used with caution in pregnancy and while taking other sedatives or alcohol.

In regulatory and clinical practice, antitussiva are chosen based on cough type, patient age, and risk factors. They are generally not helpful for coughs accompanying fever, infection requiring antibiotics, or chronic cough of uncertain origin, and should be used only as directed.